ReviewLife (Basel, Switzerland)2023
Performance of Deep-Learning Solutions on Lung Nodule Malignancy Classification: A Systematic Review.
Review in Life (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.
- Predictive Performance of Radiomics-Based Machine Learning for Colorectal Cancer Recurrence Risk: Systematic Review and Meta-Analysis.JMIR medical informatics · 2025Pooled it
- Parameter-Efficient LoRA-GRL Adaptation for Cross-Center Classification of Benign and Malignant Lung Nodules on Heterogeneous Standard-Dose Chest CT: A Multi-Institutional Study from Palestine.Journal of imaging · 2026Article
- Differential diagnosis model for tuberculous and malignant pleural effusion combining U-Net automatic segmentation and deep learning.Frontiers in medicine · 2026Article
- Advantages of integrating artificial intelligence and spectral CT for lung nodule classification and prognostic judgment: a narrative review.Journal of thoracic disease · 2025Review
- New developments in the imaging of lung cancer.Breathe (Sheffield, England) · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveFor several years, computer technology has been utilized to diagnose lung nodules. When compared to traditional machine learning methods for image processing, deep-learning methods can improve the accuracy of lung nodule diagnosis by avoiding the laborious pre-processing step of the picture (extraction of fake features, etc.). Our goal is to investigate how well deep-learning approaches classify lung nodule malignancy.
methodWe evaluated the performance of deep-learning methods on lung nodule malignancy classification via a systematic literature search. We conducted searches for appropriate articles in the PubMed and ISI Web of Science databases and chose those that employed deep learning to classify or predict lung nodule malignancy for our investigation. The figures were plotted, and the data were extracted using SAS version 9.4 and Microsoft Excel 2010, respectively.
resultsSixteen studies that met the criteria were included in this study. The articles classified or predicted pulmonary nodule malignancy using classification and summarization, using convolutional neural network (CNN), autoencoder (AE), and deep belief network (DBN). The AUC of deep-learning models is typically greater than 90% in articles. It demonstrated that deep learning performed well in the diagnosis and forecasting of lung nodules.
conclusionIt is a thorough analysis of the most recent advancements in lung nodule deep-learning technologies. The advancement of image processing techniques, traditional machine learning techniques, deep-learning techniques, and other techniques have all been applied to the technology for pulmonary nodule diagnosis. Although the deep-learning model has demonstrated distinct advantages in the detection of pulmonary nodules, it also carries significant drawbacks that warrant additional research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.